Acute Kidney Injury Clinical Trials in Cincinnati, Ohio

6 studies are recruiting for acute kidney injury in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

   This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to C…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Cincinnati, Cincinnati, Ohio

   Locations

   36 in total

   Run by

   SeaStar Medical

   See if you can join NCT05758077 on ClinicalTrials.gov

2. Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

   The goal of the BRAVE-HEART study is to learn if an amino acid infusion can reduce the risk of developing acute kidney injury after cardiac surgery in children. The main questions it aims to answer are: 1. Does an amino acid infusion decrease the number of participants with acute kidney injury? 2. …

   Stage

   Phase 2

   Ages

   Up to 18

   Site

   Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

   Run by

   Dana Fuhrman

   See if you can join NCT07212595 on ClinicalTrials.gov

3. FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

   The goal of this study is to learn whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe acute kidney injury (AKI). The main question it aims to answer is: Does implementing…

   Stage

   Not phased

   Ages

   Any age

   Site

   Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT07718464 on ClinicalTrials.gov

4. QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

   QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients…

   Stage

   Not phased

   Ages

   Up to 22

   Site

   Cincinnati Children's Hospital, Cincinnati, Ohio

   Locations

   15 in total

   Run by

   SeaStar Medical

   See if you can join NCT06517810 on ClinicalTrials.gov

5. Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

   Patients with renal insufficiency who undergo cardiac surgery with cardiopulmonary bypass (CPB) are at significant risk for exacerbation of renal dysfunction postoperatively. This in turn is associated with an increased risk of prolonged intensive care unit (ICU) length of stay, other comorbidities…

   Stage

   Not phased

   Ages

   22 to 85

   Site

   University of Cincinnati, Cincinnati, Ohio

   Locations

   7 in total

   Run by

   3ive Labs

   See if you can join NCT07017933 on ClinicalTrials.gov

6. Nafamostat Efficacy in Phase 3 Registrational CRRT Study

   A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for blee…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

   Locations

   10 in total

   Run by

   Talphera, Inc

   See if you can join NCT06150742 on ClinicalTrials.gov